Shandong Bailong Chuangyuan Bio-tech Co.,Ltd

Shandong Bailong Chuangyuan Bio-tech Co.,Ltd

Good News | Bailong Chuangyuan Recognized in the 2026 China Brand Value Evaluation — Brand Strength Validated by Both Authoritative Institutions and the Market

2026 05/12

On May 10th — China's 10th "China Brand Day" — the 2026 China Brand Value Evaluation release event was held in Deqing, Zhejiang. The event was co-organized by the China Council for Brand Development and the Xinhua News Agency Brand Affairs Office, and hosted by China Brand magazine. It stands as one of the most authoritative and professionally rigorous public brand recognition events in China.
 
Brand list-BLCY
 
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (Stock Code: 605016) was once again selected for the ranking, with its brand value continuing to rise — driven by deep brand heritage, strong technical capabilities, and outstanding industry influence. This recognition further cements Bailong Chuangyuan's position as a benchmark enterprise in China's functional sugar industry.
 
As a leading company in the field of healthy functional ingredients, Bailong Chuangyuan has dedicated over 20 years to the industry, consistently guided by the principles of technology-driven innovation, uncompromising quality, and brand-centered development. Recognized as a National High-Tech Enterprise and a "Little Giant" Specialized & Innovative enterprise, the company has built deep expertise across three core product categories: prebiotics, dietary fiber, and healthy sweeteners.
 
With independent innovation as its driving force, Bailong Chuangyuan has established strong technological barriers and a comprehensive R&D system. The company holds over 90 authorized patents (including international patents) and has led or participated in the development of multiple national and industry standards, continuously driving technological advancement across the sector. Backed by this innovation strength, Bailong Chuangyuan's products are supplied long-term to leading customers both domestically and internationally, with its global market share steadily growing.
 
Being included in the 2026 China Brand Value Evaluation represents dual recognition from authoritative institutions and the market alike — and with this honor comes greater responsibility. Looking ahead, Bailong Chuangyuan will seize this milestone as new momentum: staying true to its founding mission, deepening its core business, and pursuing continuous innovation. The company is committed to enhancing its brand competitiveness, delivering superior products, cutting-edge technology, and a stronger global brand presence — empowering the global health industry and contributing the "Bailong strength" to the high-quality development of Chinese brands worldwide.